SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: AlienTech who wrote (12790)8/6/1998 6:25:00 PM
From: VLAD  Respond to of 23519
 
alien,

Looks like Ceph was a steal a few days ago below 5.

Not a bad company to compare to Vivus.

A biotech stock

Really only one product approved for narcolepsy and maybe the myotropin will get FDA approval but both these drugs have a limited patient base.

Similar floats

Ceph has never turned a profit and has a 1 year trailing earnings of more than $2.00/share compared to Vivus' .35